Experimental immune therapy takes on stage IV cancers
Disease control
Completed
This early-stage trial tested a combination of immune cells in 9 people with stage IV solid tumors that had stopped responding to standard treatments. The main goal was to see if the therapy is safe and to check for any signs that it might control the disease. The study is now co…
Phase: PHASE1 • Sponsor: Seoul Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC